These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34078528)

  • 1. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
    Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
    BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
    Nakahara T; Hyogo H; Ono A; Nagaoki Y; Kawaoka T; Miki D; Tsuge M; Hiraga N; Hayes CN; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Abe-Chayama H; Furusho H; Shintani T; Kurihara H; Miyauchi M; Takata T; Arihiro K; Chayama K
    J Gastroenterol; 2018 Feb; 53(2):269-280. PubMed ID: 28741270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
    Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
    J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice.
    Lee SM; Muratalla J; Karimi S; Diaz-Ruiz A; Frutos MD; Guzman G; Ramos-Molina B; Cordoba-Chacon J
    Cell Mol Life Sci; 2023 Jan; 80(2):39. PubMed ID: 36629912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
    Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
    Cells; 2021 May; 10(6):. PubMed ID: 34072832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
    Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
    Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
    BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
    Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
    Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice.
    Huang CC; Chou CA; Chen WY; Yang JL; Lee WC; Chen JB; Lee CT; Li LC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice.
    Li H; Yang H; Ding Y; Aprecio R; Zhang W; Wang Q; Li Y
    J Periodontal Res; 2013 Oct; 48(5):582-90. PubMed ID: 23317150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
    Yang Q; Shu F; Gong J; Ding P; Cheng R; Li J; Tong R; Ding L; Sun H; Huang W; Wang Z; Yang L
    J Ethnopharmacol; 2020 Jun; 255():112556. PubMed ID: 31926984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
    Zhu H; Zhao T; Zhao S; Yang S; Jiang K; Li S; Kang Y; Yang Z; Shen J; Shen S; Tao H; Xuan J; Yang M; Xu B; Wang F; Jiang M
    Metabolism; 2024 Jul; 156():155914. PubMed ID: 38642829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF-κB signaling pathway.
    Yao C; Lan D; Li X; Wang Y; Qi S
    Oral Dis; 2024 Apr; 30(3):1680-1694. PubMed ID: 36939447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice.
    Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC
    Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.
    Steneberg P; Sykaras AG; Backlund F; Straseviciene J; Söderström I; Edlund H
    J Biol Chem; 2015 Jul; 290(31):19034-43. PubMed ID: 26085100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Outcomes of Rosiglitazone Treatment on Fatty Liver.
    Gao M; Ma Y; Alsaggar M; Liu D
    AAPS J; 2016 Jul; 18(4):1023-31. PubMed ID: 27125895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise training suppresses scavenger receptor CD36 expression in kupffer cells of nonalcoholic steatohepatitis model mice.
    Kawanishi N; Mizokami T; Yada K; Suzuki K
    Physiol Rep; 2018 Dec; 6(23):e13902. PubMed ID: 30516003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.